Starling Medical develops at-home health monitoring solutions, focusing on the UrinDx device for tracking urinary health and providing real-time preventative care insights.
Founded
2019
Revenue
$1-5M
Company Stage
Seed
YC Batch
W22
Product Features & Capabilities
UrinDx™ at-home urine monitoring device, real-time health insights, daily monitoring, seamless care from home, dedicated care team, insurance reimbursement, patient-driven monitoring, proactive care with nurse-monitored dashboard, user-facing smartphone app.
How much Starling Medical raised
1 - $3.4 million
September 29, 2020
Lead Investor: Rebel Fund, Coho Deeptech, and others.